Watch More Highlights
Lisa Nodzon, PhD, ARNP, AOCNP, of the H. Lee Moffitt Cancer Center & Research Institute, discusses potential new treatment strategies for patients with myelofibrosis that advanced practitioners should be aware of, including anemia therapy in combination with a JAK inhibitor, first-line combination treatments, new second-line therapies, and strategies for patients with very low platelets.